BE799141A - Composition pharmaceutique utilisable pour le traitement de l'obesite - Google Patents

Composition pharmaceutique utilisable pour le traitement de l'obesite

Info

Publication number
BE799141A
BE799141A BE130788A BE130788A BE799141A BE 799141 A BE799141 A BE 799141A BE 130788 A BE130788 A BE 130788A BE 130788 A BE130788 A BE 130788A BE 799141 A BE799141 A BE 799141A
Authority
BE
Belgium
Prior art keywords
obesity
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BE130788A
Other languages
English (en)
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of BE799141A publication Critical patent/BE799141A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE130788A 1972-05-11 1973-05-04 Composition pharmaceutique utilisable pour le traitement de l'obesite BE799141A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2210572A GB1435916A (en) 1972-05-11 1972-05-11 Pharmaceutical weight-reducing compositions

Publications (1)

Publication Number Publication Date
BE799141A true BE799141A (fr) 1973-11-05

Family

ID=10173983

Family Applications (1)

Application Number Title Priority Date Filing Date
BE130788A BE799141A (fr) 1972-05-11 1973-05-04 Composition pharmaceutique utilisable pour le traitement de l'obesite

Country Status (8)

Country Link
JP (1) JPS4947519A (fr)
AU (1) AU5561973A (fr)
BE (1) BE799141A (fr)
DE (1) DE2323906A1 (fr)
FR (1) FR2183979A1 (fr)
GB (1) GB1435916A (fr)
IL (1) IL42145A0 (fr)
NL (1) NL7306507A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
FR2619007B1 (fr) * 1987-08-07 1990-09-28 Dermatologiques Et Preparations cosmetiques a action lipolytique
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
CN1043473C (zh) * 1993-05-06 1999-05-26 默里尔多药物公司 8位取代黄嘌呤作为选择性腺苷受体药物
AT413943B (de) * 2004-03-05 2006-07-15 Lohninger Alfred Dr L-carnitin enthaltende, oral verabreichbare zusammensetzung
GB2457710A (en) * 2008-02-25 2009-08-26 Andrew Nicolaou Thyroxine and its use in weight loss and obesity treatment

Also Published As

Publication number Publication date
IL42145A0 (en) 1973-06-29
GB1435916A (en) 1976-05-19
DE2323906A1 (de) 1973-11-22
FR2183979A1 (fr) 1973-12-21
NL7306507A (fr) 1973-11-13
JPS4947519A (fr) 1974-05-08
AU5561973A (en) 1974-11-14

Similar Documents

Publication Publication Date Title
BE785004A (fr) Procede et composition pour le traitement de l'eau
BE822770A (fr) Composition pour le traitement de la diarrhee
RO61846A (fr) Procede pour le traitement du boue rouge
BE807080A (fr) Compositions pour le traitement de surfaces
BE770725A (fr) Procédé pour le traitement d'electrodes
BE828555A (fr) Composition pour le traitement d'infections virales
BE764305A (fr) Agent therapeutique pour le traitement des conditions inflamatoires.
CH550853A (fr) Composition pour le traitement des textiles.
BE793792A (fr) Compositions pour le traitement de la peau
BE799141A (fr) Composition pharmaceutique utilisable pour le traitement de l'obesite
BE761444A (fr) Nouvelles compositions pharmaceutiques pour le traitement d'infections microbiennes
BE792259A (fr) Procede et nouvelles compositions pour le traitement de la chevelure
BE754628A (fr) Retracteur pour le traitement des hemorroides
BE789839A (fr) Procede pour le traitement superficiel d'articles
BE792260A (fr) Procede et composition pour le traitement de la
BE841885Q (fr) Composition et procede pour le traitement de ruminants
BE765352A (fr) Procede et composition pour le traitement de la
BE792421A (fr) Agent pour le traitement des hyperlipoproteinemies et son procede de preparation
BE815397A (fr) Conposes pour le traitement de tumeurs calciques
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE780777A (fr) Engin mobile pour le traitement des ordures
RO63671A (fr) Procede pour la preparation des cycloalcanomes et des cycloalcanoles
BE812974A (fr) Compositions pharmaceutiques pour le traitement des ulceres
BE791253A (fr) Nouvelles preparations pharmaceutiques pour le traitement de l'hypertonie
BE774917A (fr) Composition pour le traitement des cheveux et procede de preparation decette composition